Jump to:
loading...| Preferred Name |
Omalizumab |
|
| Synonyms |
|
|
| Definitions |
A humanized monoclonal antibody directed against the C-epsilon 3 domain of immunoglobulin E. Olizumab binds to this IgE domain, thereby preventing IgE from binding to its high-affinity mast-cell receptor. (NCI04) |
|
| ID |
http://purl.obolibrary.org/obo/NCIT_C29299 |
|
| CAS_Registry |
242138-07-4 |
|
| code |
C29299 |
|
| Contributing_Source |
FDA |
|
| definition |
A humanized monoclonal antibody directed against the C-epsilon 3 domain of immunoglobulin E. Olizumab binds to this IgE domain, thereby preventing IgE from binding to its high-affinity mast-cell receptor. (NCI04) |
|
| FDA_UNII_Code |
2P471X1Z11 |
|
| in_subset | ||
| label |
Omalizumab |
|
| Legacy Concept Name |
Olizumab |
|
| Preferred_Name |
Omalizumab |
|
| prefixIRI |
NCIT:C29299 |
|
| prefLabel |
Omalizumab |
|
| Semantic_Type |
Amino Acid, Peptide, or Protein Pharmacologic Substance Immunologic Factor |
|
| UMLS_CUI |
C0966225 |
|
| subClassOf |
Create mapping